ExploreWatchlistsPricing
  1. JP-listed companies
  2. SYSMEX CORPORATION
  3. Financials
  4. Marketable securities, current

SYSMEX CORPORATION (6869)

Market cap
¥901.4B
P/E ratio
21.8x
Develops and manufactures medical testing equipment and reagents for blood tests and urinalysis, serving healthcare institutions worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndMarketable securities, current (Million JPY)YoY (%)
Mar 31, 2025654-50.08%
Mar 31, 20241,310+49.71%
Mar 31, 2023875-41.59%
Mar 31, 20221,498+35.57%
Mar 31, 20211,105+162.47%
Mar 31, 2020421-94.49%
Mar 31, 20197,644+3471.96%
Mar 31, 2018214-28.43%
Mar 31, 2016299+24.58%
Mar 31, 2015240

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat